Fresh analysis reveals that individuals who discontinue new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who halt traditional lifestyle regimens.
Findings released in a prominent medical journal demonstrates that while obese people often shed a large proportion of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Users using such drugs need to be aware of the danger of fast rebound weight gain when the medication ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to pre-treatment weight within about a year and a half.
Comparing Therapies
The analysis, which examined 37 of trials involving thousands of patients, compared the results of GLP-1 agonists with conventional dieting.
Scientists emphasize that people who lose weight through lifestyle changes alone generally see a less rapid creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Quick Regain
Experts suggest the mode of action of the drugs accounts for the heightened rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication leads to hunger is no longer kept in check, making binge eating far more likely."
A Lifelong Issue?
The NHS advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals say that, due to the high risk of weight regain, the treatment is often life-long.
This perspective is reinforced by drug manufacturers, who state that the findings "underscore the chronic character of excess weight," similar to managing conditions like hypertension.
Patient Experiences
Users who have discontinued the medication explain a powerful return of cravings.
"It was like something flipping and you become ravenous," recalled a patient.
The struggle is worsened if individuals have not developed permanent lifestyle or habit modifications during treatment.
Significant Use
Recent estimates indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with interest being substantial.
- Adoption is higher among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- Many access the drugs through private prescriptions rather than public health services.
Finally, researchers caution that while the jabs are potent tools for shedding pounds, they are not a permanent solution and lasting health benefits hinges on combined lifestyle changes.
